21 C.F.R. § 516.23

Timing of requests for MUMS-drug designation.

Last amended: 2016Year: 2026Length: 37 wordsOfficial source

Cite as 21 C.F.R. § 516.23 (2026)

A sponsor may request MUMS-drug designation at any time in the drug development process prior to the submission of an application for either conditional approval or approval of the MUMS drug for which designation is being requested.
21 C.F.R. § 516.23: Timing of requests for MUMS-drug designation. | Justis AI